When evaluated against other specialty chemical and polymer manufacturing enterprises across European and global industrial sectors, Synthomer has historically experienced greater earnings volatility due to its historical exposure to commoditized latex markets and high debt burdens resulting from past acquisitions. However, its strategic pivot toward differentiated, high-margin functionalized polymers aims to align its performance more closely with stable specialty chemical peers, even as it continues working to repair its balance sheet and improve return on capital metrics.